MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 142 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $38,000 | -62.7% | 30,392 | -8.1% | 0.00% | -100.0% |
Q1 2017 | $102,000 | -29.2% | 33,075 | -6.0% | 0.00% | 0.0% |
Q4 2016 | $144,000 | -38.7% | 35,175 | -4.8% | 0.00% | -50.0% |
Q3 2016 | $235,000 | +30.6% | 36,931 | +10.5% | 0.00% | 0.0% |
Q2 2016 | $180,000 | -40.0% | 33,431 | -6.8% | 0.00% | -33.3% |
Q1 2016 | $300,000 | +7.9% | 35,881 | +1.9% | 0.00% | 0.0% |
Q4 2015 | $278,000 | -5.4% | 35,216 | +2.0% | 0.00% | 0.0% |
Q3 2015 | $294,000 | -13.8% | 34,515 | +25.2% | 0.00% | 0.0% |
Q2 2015 | $341,000 | +76.7% | 27,565 | +69.9% | 0.00% | +50.0% |
Q1 2015 | $193,000 | – | 16,225 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 775,571 | $2,389,000 | 0.93% |
KEMPNER CAPITAL MANAGEMENT INC. | 148,985 | $459,000 | 0.31% |
Yakira Capital Management, Inc. | 248,420 | $765,000 | 0.27% |
GARRISON BRADFORD & ASSOCIATES INC | 87,700 | $270,000 | 0.24% |
Cannell & Co. | 1,212,478 | $3,734,000 | 0.13% |
LeJeune Puetz Investment Counsel LLC | 3,976 | $180,000 | 0.13% |
ALPINE WOODS CAPITAL INVESTORS, LLC | 726,000 | $2,236,000 | 0.12% |
Virtus ETF Advisers LLC | 198,735 | $612,000 | 0.11% |
STONERIDGE INVESTMENT PARTNERS LLC | 199,227 | $614,000 | 0.08% |
Birchview Capital, LP | 44,000 | $136,000 | 0.08% |